Skip to content

Cyproterone

Cyproterone blocks androgen effects and suppresses androgen production. Because it has important liver, clot and meningioma risks, use should be limited to a clearly assessed indication.

Diane 35

Acne Vulgaris, Hirsutism

2/0.035mg

Cyproterone with ethinylestradiol as a film-coated tablet, used in the management of acne and hirsutism. An anti-androgen paired with an oestrogen.

From$1.03/ tabletView

Cyproterone Acetate and Ethinylestradiol Tablets

Severe Acne, Hirsutism, Androgenetic Alopecia

2/0.035mg

Cyproterone acetate with ethinylestradiol as a film-coated tablet, used for severe acne, hirsutism and androgenetic alopecia. An anti-androgen with an oestrogen.

From$1.03/ tabletView

Key points

  • Cyproterone is not a routine first choice for mild acne, unwanted hair growth or hair loss.
  • Pregnancy, liver disease, clot history and previous or current meningioma require review.
  • Severe headache with neurological change, jaundice or symptoms of a blood clot needs urgent care.

Listings are for comparison only. Suitability and supply depend on clinician and pharmacy checks, stock, destination rules and prescription requirements.

What Cyproterone is used for

It may be used in selected severe androgen-related conditions such as hirsutism or severe acne when other treatment is unsuitable. Uses and combination ingredients vary by product.

How it works

Cyproterone blocks androgen receptors and has progestogenic effects that reduce gonadotropin-driven androgen production.

Important safety checks

Pregnancy must be excluded where relevant. Liver function, clot risk, mood, bone health and cumulative exposure require review. New persistent headache, hearing or vision change, weakness or seizure can signal a meningioma and should be assessed promptly.

When to seek urgent care

Seek urgent help for chest pain, sudden breathlessness, coughing blood, one-sided leg swelling, yellow skin or eyes, a new seizure, or severe headache with weakness, speech, hearing or visual change.

Further reading